| Date Filed | Type | Description |
| 12/07/2021 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 11.9% stake in Madrigal Pharmaceuticals, Inc. |
| 09/04/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 18.6% stake in Madrigal Pharmaceuticals, Inc. |
| 06/01/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 27.9% stake in Madrigal Pharmaceuticals, Inc. |
| 02/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/13/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 6.5% stake in Dermira, Inc. |
| 12/13/2019 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 27.1% stake in Madrigal Pharmaceuticals, Inc. |
| 10/17/2019 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 34.8% stake in Madrigal Pharmaceuticals, Inc. |
| 11/28/2018 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 9.3% stake in Merus N.V. |
| 02/10/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/02/2016 |
SC 13G/A
| NEVRO CORP reports a 2.5% stake in Nevro Corp. |
| 08/05/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 07/29/2016 |
SC 13D
| Madrigal Pharmaceuticals, Inc. reports a 49.9% stake in Madrigal Pharmaceuticals, Inc. |
| 05/27/2016 |
SC 13D
| Merus B.V. reports a 13.1% stake in Merus N.V. |
| 07/22/2013 |
SC 13D/A
| HYPERION THERAPEUTICS INC reports a 10.6% stake in Hyperion Therapeutics, Inc. |
| 06/07/2013 |
SC 13D
| Epizyme, Inc. reports a 12.9% stake in Epizyme, Inc. |
| 02/27/2013 |
SC 13G
| TENGION INC reports a 10% stake in Tengion, Inc. |
| 08/02/2012 |
SC 13D
| HYPERION THERAPEUTICS INC reports a 14.8% stake in Hyperion Therapeutics, Inc. |
| 02/10/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| BAY CITY CAPITAL LLC reports a 7.2% stake in Cadence Pharmaceuticals, Inc. |
| 11/17/2010 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 93.6% stake in VIA Pharmaceuticals, Inc. |
| 07/01/2010 |
SC 13D/A
| BAY CITY CAPITAL LLC has filed a Schedule 13D for Sunesis Pharmaceuticals, Inc. |
| 03/30/2010 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 91.3% stake in VIA Pharmaceuticals, Inc. |
| 01/19/2010 |
SC 13G/A
| CADENCE PHARMACEUTICALS INC has filed a Schedule 13D for Cadence Pharmaceuticals, Inc. |
| 11/03/2009 |
SC 13D/A
| BAY CITY CAPITAL LLC has filed a Schedule 13D for Sunesis Pharmaceuticals, Inc. |
| 04/13/2009 |
SC 13D
| Form SC 13D -- General statement of acquisition of beneficial ownership |
| 02/20/2009 |
SC 13G
| BAY CITY CAPITAL LLC has filed a Schedule 13D for Cadence Pharmaceuticals, Inc. |